MedPath

Title: Effect of Clonidine on Post-operative Nausea and Vomiting in Breast Cancer Surgery

Phase 2
Conditions
D05.10
Breast Cancer.
Intraductal carcinoma in situ of unspecified breast
Registration Number
IRCT20141009019470N99
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
68
Inclusion Criteria

Patients Candidate for Breast Cancer Surgery
Ages 15 to 70 years
ASA Class I-II
General Anesthesia

Exclusion Criteria

A history of postoperative nausea and vomiting
Patients who have received antiemetic drugs such as ondansetron or dexamethasone 24 hours before surgery
History of motion sickness
Allergy to Propofol and Clonidine
Concomitant use of beta-blocker medication that may affect a patient's heart rate
Systolic blood pressure less than 100
History of using Steroid
History of myocardial infarction
History of tricyclic antidepressant use
History of kidney dysfunction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post-operative Nausea and Vomiting. Timepoint: Postoperative nausea and vomiting in recovery is recorded at 0-15-30 and 45 minutes. After transferring the patient to the surgical ward, the incidence of postoperative nausea and vomiting is evaluated at 6 and 24 hours. Method of measurement: Likert.
Secondary Outcome Measures
NameTimeMethod
Hemodynamic changes. Timepoint: Blood pressure and heart rate are recorded in the surgical ward in the operating room before induction after induction and in recovery at 0-15-30 and 45 minutes.After transferring the patient to the surgical ward, the patient's blood pressure is checked at 24,2,4,6,12 hours. Method of measurement: Monitoring.
© Copyright 2025. All Rights Reserved by MedPath